Amrize (NYSE:AMRZ) Now Covered by Oppenheimer

Key Points

• Oppenheimer has initiated coverage on Amrize (NYSE:AMRZ) with an "outperform" rating and a price target of $62.00, suggesting a potential upside of 12.27% from the stock's last close.
• Amrize's recent quarterly earnings report showed an EPS of $0.78, missing analyst expectations of $1.03 by $0.25.
• The stock has experienced significant insider buying recently, with insiders acquiring over 1 million shares worth more than $53 million in the last 90 days.

Oppenheimer assumed coverage on shares of Amrize (NYSE:AMRZ - Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. The firm issued an outperform rating and a $62.00 target price on the stock.

A number of other analysts have also recently commented on the company. Zacks Research cut Amrize from a "hold" rating to a "strong sell" rating in a research report on Wednesday, August 27th. JPMorgan Chase & Co. lifted their price target on Amrize from $52.00 to $60.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 26th. Finally, Royal Bank Of Canada lowered their price target on Amrize from $61.00 to $54.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $58.67.

Amrize Stock Performance

AMRZ traded down $0.47 on Tuesday, reaching $55.16. 3,568,197 shares of the stock were exchanged, compared to its average volume of 2,241,884. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $56.29. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42.

Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts' consensus estimates of $1.03 by ($0.25).

Insiders Place Their Bets

In related news, insider Jaime Hill acquired 4,000 shares of the firm's stock in a transaction dated Friday, August 8th. The stock was acquired at an average price of $46.40 per share, with a total value of $185,600.00. Following the acquisition, the insider directly owned 9,601 shares in the company, valued at $445,486.40. This represents a 71.42% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Stephen S. Clark acquired 5,000 shares of the firm's stock in a transaction dated Friday, August 15th. The stock was bought at an average cost of $51.82 per share, with a total value of $259,100.00. Following the acquisition, the insider owned 5,000 shares in the company, valued at approximately $259,100. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 1,124,000 shares of company stock worth $53,225,260.

Hedge Funds Weigh In On Amrize

Large investors have recently bought and sold shares of the business. BNP Paribas Financial Markets acquired a new position in Amrize in the 2nd quarter worth about $59,000. Groupe la Francaise acquired a new position in Amrize in the 2nd quarter worth about $60,000. Allianz SE acquired a new position in Amrize in the 2nd quarter worth about $80,000. Osaic Holdings Inc. acquired a new position in Amrize in the 2nd quarter worth about $90,000. Finally, Credit Industriel ET Commercial acquired a new position in Amrize in the 2nd quarter worth about $109,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.